Analysis of the mechanism by which TSLP production is inhibited by PHD inhibitors
Makiko Yagisawa, Ryosuke Segawa, Naoyuki Tashiro, Noriyasu Hirasawa
Abstract
Open-access reader
Makiko Yagisawa, Ryosuke Segawa, Naoyuki Tashiro, Noriyasu Hirasawa
Abstract
Open-access reader
Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine that plays an important role in the regulation of skin immunity and is upregulated in the lesions of atopic dermatitis patients. Therefore, inhibitors of TSLP production are effective as therapeutic agents for atopic dermatitis. In our laboratory, we found that hypoxia condition and DMOG, a PHD inhibitor, suppressed the expression of TSLP in keratinocytes. In this study, we analyzed the mechanism by which PHD inhibitors suppress TSLP expression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine that plays an important role in the regulation of skin immunity and is upregulated in the lesions of atopic dermatitis patients. Therefore, inhibitors of TSLP production are effective as therapeutic agents for atopic dermatitis. In our laboratory, we found that hypoxia condition and DMOG, a PHD inhibitor, suppressed the expression of TSLP in keratinocytes. In this study, we analyzed the mechanism by which PHD inhibitors suppress TSLP expression.
Key concepts: Thymic stromal lymphopoietin, Atopic dermatitis, Mechanism (biology), Cytokine, Downregulation and upregulation, Immunology, Chemistry, Medicine